| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |